“Cardiovascular disease and COPD: dangerous liaisons?” Klaus F. Rabe, John R. Hurst and Samy Suissa. Eur Respir Rev 2018; 27: 180057.


Source: Eur Respir Rev, 27 (150) 185057; 10.1183/16000617.5057-2018
Journal Issue: December
Disease area: Airway diseases

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
“Cardiovascular disease and COPD: dangerous liaisons?” Klaus F. Rabe, John R. Hurst and Samy Suissa. Eur Respir Rev 2018; 27: 180057.. Eur Respir Rev, 27 (150) 185057; 10.1183/16000617.5057-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
“Is bronchiectasis really a disease?” Michal Shteinberg, Patrick A. Flume and James D. Chalmers. Eur Respir Rev 2020; 29: 190051.
Source: Eur Respir Rev, 29 (155) 195051; 10.1183/16000617.5051-2019
Year: 2020


“Advanced medical interventions in pleural disease.” Rahul Bhatnagar, John P. Corcoran, Fabien Maldonado, David Feller-Kopman, Julius Janssen, Philippe Astoul and Najib M. Rahman. Eur Respir Rev 2016; 25: 199–213.
Source: Eur Respir Rev 2016; 25: 360
Year: 2016


“Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes.” Sabina A. Guler, Joanne M. Kwan, Janice M. Leung, Nasreen Khalil, Pearce G. Wilcox and Christopher J. Ryerson. Eur Respir J 2020; 55: 1900647.
Source: Eur Respir J, 55 (3) 1950647; 10.1183/13993003.50647-2019
Year: 2020



“Adult-onset asthma: is it really different?” Selma B. de Nijs, Lisette N. Venekamp and Elisabeth H. Bel. Eur Respir Rev 2013; 22: 44–52.
Source: Eur Respir Rev 2013; 22: 193
Year: 2013


“Cellular mechanisms underlying steroid-resistant asthma.” Ridhima Wadhwa, Kamal Dua, Ian M. Adcock, Jay C. Horvat, Richard Y. Kim and Philip M. Hansbro. Eur Respir Rev 2019; 28: 190021.
Source: Eur Respir Rev, 28 (154) 195096; 10.1183/16000617.5096-2019
Year: 2019


“Idiopathic inflammatory myopathies and the lung.” Jean-Christophe Lega, Quitterie Reynaud, Alexandre Belot, Nicole Fabien, Isabelle Durieu and Vincent Cottin. Eur Respir Rev 2015; 24: 216–238.
Source: Eur Respir Rev 2015; 24: 545
Year: 2015


“Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.” Michael Kreuter, Marlies S. Wijsenbeek, Martina Vasakova, Paolo Spagnolo, Martin Kolb, Ulrich Costabel, Derek Weycker, Klaus-Uwe Kirchgaessler and Toby M. Maher. Eur Respir J 2016; 47: 1776–1784.
Source: Eur Respir J 2016; 48: 593
Year: 2016


“Echocardiographic assessment of pulmonary hypertension: standard operating procedure.” Luke S. Howard, Julia Grapsa, David Dawson, Michael Bellamy, John B. Chambers, Navroz D. Masani, Petros Nihoyannopoulos and J. Simon R. Gibbs. Eur Respir Rev 2012; 125: 239–248.
Source: Eur Respir Rev 2012 21: 370
Year: 2012


“Contact investigation for tuberculosis: a systematic review and meta-analysis.” Gregory J. Fox, Simone E. Barry, Warwick J. Britton and Guy B. Marks. Eur Respir J 2013; 41: 140–156.
Source: Eur Respir J 2015; 46: 578
Year: 2015


“Characterisation of patients with interstitial pneumonia with autoimmune features.” Justin M. Oldham, Ayodeji Adegunsoye, Eleanor Valenzi, Cathryn Lee, Leah Witt, Lena Chen, Aliya N. Husain, Steven Montner, Jonathan H. Chung, Vincent Cottin, Aryeh Fischer, Imre Noth, Rekha Vij and Mary E. Strek. Eur Respir J 2016; 47: 1767–1775.
Source: Eur Respir J, 49 (5) 1551565; 10.1183/13993003.51565-2015
Year: 2017


“Exertional dyspnoea in COPD: the clinical utility of cardiopulmonary exercise testing.” Denis E. O'Donnell, Amany F. Elbehairy, Azmy Faisal, Katherine A. Webb, J. Alberto Neder and Donald A. Mahler. Eur Respir Rev 2016; 25: 333–347.
Source: Eur Respir Rev 2016; 25: 513
Year: 2016



“Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.” Claus F. Vogelmeier, Gerard J. Criner, Fernando J. Martinez, Antonio Anzueto, Peter J. Barnes, Jean Bourbeau, Bartolome R. Celli, Rongchang Chen, Marc Decramer, Leonardo M. Fabbri, Peter Frith, David M.G. Halpin, M. Victorina López Varela, Masaharu Nishimura, Nicolas Roche, Roberto Rodriguez-Roisin, Don D. Sin, Dave Singh, Robert Stockley, Jørgen Vestbo, Jadwiga A. Wedzicha and Alvar Agusti. Eur Respir J 2017; 49: 1700214.
Source: Eur Respir J, 49 (6) 1750214; 10.1183/13993003.50214-2017
Year: 2017


“Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.” Irene Lang, Bernhard C. Meyer, Takeshi Ogo, Hiromi Matsubara, Marcin Kurzyna, Hossein-Ardeschir Ghofrani, Eckhard Mayer and Philippe Brenot. Eur Respir Rev 2017; 26: 160119.
Source: Eur Respir Rev, 26 (144) 165119; 10.1183/16000617.5119-2016
Year: 2017


“Metabolic dysfunction in pulmonary hypertension: from basic science to clinical practice.” Stephen Y. Chan and Lewis J. Rubin. Eur Respir Rev 2017; 26: 170094.
Source: Eur Respir Rev, 27 (147) 175094; 10.1183/16000617.5094-2017
Year: 2018


“Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis.” Kevin R. Flaherty, Charlene D. Fell, J. Terrill Huggins, Hilario Nunes, Robert Sussman, Claudia Valenzuela, Ute Petzinger, John L. Stauffer, Frank Gilberg, Monica Bengus and Marlies Wijsenbeek. Eur Respir J 2018; 52: 1800230.
Source: Eur Respir J, 52 (4) 1850230; 10.1183/13993003.50230-2018
Year: 2018


“Differential diagnosis of usual interstitial pneumonia: when is it truly idiopathic?” Wim A. Wuyts, Alberto Cavazza, Giulio Rossi, Francesco Bonella, Nicola Sverzellati and Paolo Spagnolo. Eur Respir Rev 2014; 23: 308–319.
Source: Eur Respir Rev 2014; 23: 537
Year: 2014


“Towards a total ban on links with the tobacco industry: new rules for the ERS.” Klaus F. Rabe, Christina Gratziou, Brian Ward and Florence Berteletti. Eur Respir J 2012; 40: 809–810.
Source: Eur Respir J 2012; 40: 1307
Year: 2012


“Pulmonary arterial hypertension in patients treated with interferon.” Laurent Savale, Caroline Sattler, Sven Günther, David Montani, Marie-Camille Chaumais, Swanny Perrin, Xavier Jaïs, Andrei Seferian, Roland Jovan, Sophie Bulifon, Florence Parent, Gérald Simonneau, Marc Humbert and Olivier Sitbon. Eur Respir J 2014; 44: 1627–1634.
Source: Eur Respir J 2015; 46: 1854
Year: 2015


“Recent lessons learned in the management of acute exacerbation of idiopathic pulmonary fibrosis.” Yasuhiro Kondoh, Vincent Cottin and Kevin K. Brown. Eur Respir Rev 2017; 26: 170050.
Source: Eur Respir Rev, 27 (148) 175050; 10.1183/16000617.5050-2017
Year: 2018


“Haemoptysis due to pulmonary venous stenosis.” Silke Braun, Ivan Platzek, Klaus Zöphel, Matthias Weise, Martin Kolditz, Michael Halank and Gert Hoeffken. Eur Respir Rev 2014; 23: 170–179.
Source: Eur Respir Rev 2014; 23: 399
Year: 2014